There are 3161 resources available
Biomarker driven adjuvant therapy in locally advanced NPC
Presenter: Pierre Blanchard
Session: Recent breakthroughs in the treatment of endemic NPC
Resources:
Slides
Webcast
The WHO Pandemic Accord and the review of the International Health Regulations (IHR): The need to include cancer prevention and control
Presenter: Jose Martin-Moreno
Session: ESMO and WHO: Tackling cancer worldwide
Resources:
Slides
Webcast
Should we target single or multiple antigens?
Presenter: Cristina Puig-Saus
Session: Are we targeting the right antigens?
Resources:
Slides
Webcast
235MO - Efficacy and safety of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in younger patients (pts) with HR+/HER2− early breast cancer (EBC) in NATALEE
Presenter: Sherene Loi
Session: Mini oral session: Breast cancer, early stage
Resources:
Abstract
Slides
1256MO - Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
Presenter: Benjamin Besse
Session: Mini oral session: NSCLC metastatic
Resources:
Abstract
Slides
Webcast
Q&A
Session: Dissecting Cancer of Unknown Primary: Case presentation and expert insights
Resources:
Webcast
Q&A and discussion
Session: Molecular characterisation and novel targeted therapies in gastroesophageal and pancreatic cancer
Resources:
Webcast
Systemic treatment for thymic tumours
Presenter: Jordi Remon Masip
Session: Updates on the treatment of thymic epithelial tumours
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session: Melanoma and other skin tumours
Resources:
Webcast
T cell engagers in prostate cancer
Presenter: Neeraj Agarwal
Session: What’s on the horizon for metastatic prostate cancer patients?
Resources:
Slides
Webcast